FTC Supports Federal DTC Ad Inquiry

Share this article:
The Federal Trade Commission is supporting efforts by the Food and Drug Administration to survey patients and doctors to determine the effects of direct-to-consumer pharmaceutical advertising.


FDA officials are trying to determine the potential benefits and harms caused by DTC ads. In comments submitted Thursday to the U.S. Office of Management and Budget, the FTC proposed additional inquiries into DTC effects on insurance and drug costs.


Such surveys could help officials evaluate whether DTC ads lead to lower prescription drug prices, the FTC said.


In June, the American Medical Association called for increased disclosures in DTC drug ads due to fears that the ads drive up drug prices by convincing consumers to request brand-name drugs when cheaper generics suffice.


Pharmaceutical Research and Manufacturers of America has stated that DTC drug ads empower consumers by helping them make their own healthcare choices.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

MeritDirect Opens San Jose Office

MeritDirect Opens San Jose Office

A force in direct mail, the company looks to expand its digital data services with a footprint in Silicon Valley.

Neustar Decides to Hand Data Over to its Clients

Neustar Decides to Hand Data Over to its ...

AK Media Insights Pro turns data over to marketers to create business-specific aggregations, integrate offline efforts, and probe deeper into their sales funnels.

Arthur Hughes, Who Wrote the Book on Database Marketing, Dies at 86

Arthur Hughes, Who Wrote the Book on Database ...

First published in the early days of the Web, Arthur Middleton Hughes's Strategic Database Marketing remains a bible for direct marketers.